MassIVE MSV000087742

Partial Public

Characterization of CpeNeo mice, a conditional null mutation of carboxypeptidase E, and restoration of Cpe expression with Flp recombinase

Description

Carboxypeptidase E (CPE) is an essential enzyme that contributes to the biosynthesis of the vast majority of neuropeptides and peptide hormones. Mice lacking CPE activity due either to a natural mutation or targeted disruption of the Cpe gene have greatly decreased levels of most neuropeptides and show a large number of defects including severely impaired fertility, adult-onset obesity, anxiety- and depressive-like behavior, and abnormal hippocampal development. In the present study, we generated a mouse line named CpeNeo due to a neomycin cassette within the Cpe gene that blocks normal splicing of the gene, leading to the loss of enzyme expression. CpeNeo/Neo mice show all of the defects previously found with Cpefat/fat and/or KO mice. In addition, young adult CpeNeo/Neo mice are more sensitive to morphine-induced hyperlocomotion than wild-type mice, while older CpeNeo/Neo mice are less sensitive than wild-type mice. Removal of the neomycin cassette with Flp recombinase under a germline promoter restored the expression of CPE activity, leading to normal levels of neuropeptides in brain. CpeFlp/Flp mice are identical to wild-type mice in terms of behavior and physiology. Mice heterozygous for the CpeNeo allele have Cpe mRNA levels ~50% of wild-type mice, but are identical to wild-type mice in all behaviors and physiological parameters examined. These results confirm that CPE is not a rate-limiting enzyme in the production of most neuropeptides, despite claims that small decreases in CPE activity contribute to obesity or other physiological effects [doi:10.25345/C5MV7C] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: Metallocarboxypeptidase, carboxypeptidase E, neuropeptide, peptide hormone, GEMSA

Contact

Principal Investigators:
(in alphabetical order)
Lakshmi A. Devi, Pharmacological Science, Icahn School of Medicine at Mount Sinai, NY, USA
Lloyd D. Fricker, Molecular Pharmacology, Albert Einstein College of Medicine, NY, USA
Submitting User: aktashima
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.